Cargando…
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third coronavirus in less than 20 years to spillover from an animal reservoir and cause severe disease in humans. High impact respiratory viruses such as pathogenic beta-coronaviruses and influenza viruses, as well as other emerging...
Autores principales: | Zarkoob, Hoda, Allué-Guardia, Anna, Chen, Yu-Chi, Jung, Olive, Garcia-Vilanova, Andreu, Song, Min Jae, Park, Jun-Gyu, Oladunni, Fatai, Miller, Jesse, Tung, Yen-Ting, Kosik, Ivan, Schultz, David, Yewdell, Jonathan, Torrelles, Jordi B., Martinez-Sobrido, Luis, Cherry, Sara, Ferrer, Marc, Lee, Emily M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132232/ https://www.ncbi.nlm.nih.gov/pubmed/34013274 http://dx.doi.org/10.1101/2021.05.11.443693 |
Ejemplares similares
-
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
por: Zarkoob, Hoda, et al.
Publicado: (2022) -
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease
por: Allué-Guardia, Anna, et al.
Publicado: (2023) -
Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
por: Allué-Guardia, Anna, et al.
Publicado: (2021) -
Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023) -
Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
por: Allué-Guardia, Anna, et al.
Publicado: (2021)